Carisma Therapeutics has gone public, entered a broad collaboration with Moderna, and ceased development of its original ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

Biopharmaceutical companies must address the frictions and challenges that have quietly infiltrated the drug development ...

We live in a time of hope for millions around the world, as technological advancements and research breakthroughs hold the ...

The rapid adoption of AI in the pharmaceutical market has led to a revolution in the research process and pharmaceutical development techniques. The AI revolution is not free of risks, however. This ...

Google’s global market leader for life sciences, Shweta Maniar, spoke with Life Science Leader about how large and small biopharmaceutical companies are using AI to lower costs and expedite timelines.

Under Michael Bailey’s leadership, AVEO Oncology is building on Fotivda’s success and developing a pipeline of targeted therapeutics to improve outcomes for cancer patients.

In August 2023, Gut, a journal published by BMJ, released a study of over 24,000 patients with Parkinson’s disease, finding that certain gastrointestinal disorders — such as difficulty swallowing, ...

Privately-held Aurion Biotech is developing an allogeneic combination cell therapy — neltependocel, which is allogeneic human corneal endothelial cells, combined with Y-27632, an inhibitor of ...